LRI Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.4K Sell
30
-9
-23% -$2.37K ﹤0.01% 1008
2026
Q1
$10.4K Buy
39
+28
+255% +$7.58K ﹤0.01% 876
2025
Q4
$2.76K Sell
11
-319
-97% -$84.7K ﹤0.01% 1157
2025
Q3
$94.7K Hold
330
0.01% 428
2025
Q2
$86.6K Hold
330
0.01% 454
2025
Q1
$76.7K Buy
330
+63
+24% +$15.3K 0.01% 461
2024
Q4
$61.2K Sell
267
-13
-5% -$2.98K 0.01% 500
2024
Q3
$66.8K Buy
280
+254
+977% +$55.8K 0.01% 475
2024
Q2
$5.36K Buy
+26
New +$5.29K ﹤0.01% 873

Other funds holding LH

LRI Investments's LH Position: Q2 2026 in Review

LRI Investments reduced its Labcorp (LH) stake by 23% in Q2 2026, selling an estimated $2.37K and leaving 30 shares worth $8.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

LRI Investments first reported a position in LH in Q2 2024 and has held it in 9 quarters since. The position peaked at $94.7K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • LRI Investments held 30 shares of Labcorp worth $8.4K as of Q2 2026.
  • LRI Investments sold 9 Labcorp shares in Q2 2026, an estimated $2.37K.
  • Labcorp made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1008 holding.
  • LRI Investments first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • LRI Investments's Labcorp position peaked at $94.7K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.